US-based diagnostics company Sekisui has introduced its OSOM BVBLUE Test in Europe, Middle East and North Africa for bacterial vaginosis (BV) diagnosis.
The test has been developed to provide quick results with accuracy by detecting increased level of the enzyme sialidase produced by the four major pathogens, Gardnerella, Bacteroides, Prevotella and Mobiluncus, which trigger bacterial vaginosis.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
A rapid diagnosis of the infection facilitates the immediate and correct course of treatment, limiting aggravation of health complications.
The process involves placing a vaginal fluidsample on the BV Test Vessel and then gently swirling the mixture.
It is then allowed to stand for ten minutes in a temperature controlled between 17°to 37°C.
A drop of developer solution is then added to the solution, following which if the sample turns blue or green, the test result is positive, if yellow the test result is negative.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSekisui global sales and marketing vice-president Lee Lipski said: "Building on the successful adoption of this test in the US, we are pleased to be able to offer the OSOM BVBLUE Test internationally, which now enables physicians and laboratories in those countries to offer simple and efficient testing for both bacterial vaginosis and trichomonas infections."
The OSOM BVBLUE Test has demonstrated producing accurate results with sensitivity and specificity in clinical studies.
Image: The OSOM BVBLUE Test. Photo: courtesy of PR Newswire Association LLC / Sekisui Diagnostics.
